Overexpression of the erythropoietin receptor is associated with upregulation of tubulin beta 6 and paclitaxel resistance in ovarian adenocarcinoma cells
Acta Chimica Slovenica · 20.03.2026 · 73 (1) · 258-266
DOI: 10.17344/acsi.2025.9420 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Chimica Slovenica, online erschienen am 20.03.2026. Verfasst von Pavol Harvanik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, SK-04154 Košice, Slovak Republic. Hauptthemen laut MEDLINE: Paclitaxel, Tubulin, Ovarian Neoplasms, Drug Resistance, Neoplasm.
Abstract (Originalsprache)
The emergence of tumor cell resistance is one of the major issues in current oncology practice. It reduces the effectiveness of therapy and worsens cancer patients’ prognoses. However, it confirms a wide range of molecular interactions as well as the complexity of the human organism. Our previous research confirmed the functionality of the erythropoietin receptor (EPOR) in ovarian and breast cancer cells, as well as its relationship to these cells’ sensitivity to specific therapies. The current study demonstrates that EPOR overexpression in human ovarian adenocarcinoma cells A2780 is directly linked to paclitaxel resistance. Furthermore, EPOR overexpression results in morphological changes that vary according to the pattern of EPOR isotypes expressed. In this regard, the most interesting result appears to be the change in the shape of the T clone, which has a tendency to form spheroidal structures. In addition, functional enrichment analysis demonstrated that EPOR-associated differentially expressed genes are involved in several biological and cell processes. Indeed, a T clone with a single 68 kDa EPOR isotype demonstrates significant resistance to paclitaxel therapy and is associated with the upregulation of tubulin beta 6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Biology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, SK-04154 Košice, Slovak Republic.
- Department of Pharmacology, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, SK-04154 Košice, Slovak Republic.
- Laboratory of Biomedical Microbiology and Immunology, University of Veterinary Medicine and Pharmacy in Košice, SK-04154 Košice, Slovak Republic; Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta…
Zitieren
APA
Harvanik, P., Danková, K., Solárová, Z., Šemeláková, M., Bhide, M., & Solár, P. (2026). Overexpression of the erythropoietin receptor is associated with upregulation of tubulin beta 6 and paclitaxel resistance in ovarian adenocarcinoma cells. Acta Chimica Slovenica, 73(1), 258-266. https://doi.org/10.17344/acsi.2025.9420
Vancouver
Harvanik P, Danková K, Solárová Z, Šemeláková M, Bhide M, Solár P. Overexpression of the erythropoietin receptor is associated with upregulation of tubulin beta 6 and paclitaxel resistance in ovarian adenocarcinoma cells. Acta Chimica Slovenica. 2026;73(1):258-266. doi:10.17344/acsi.2025.9420
BibTeX
@article{Harvanik2026,
author = {Harvanik, Pavol and Danková, Kristína and Solárová, Zuzana and Šemeláková, Martina and Bhide, Mangesh and Solár, Peter},
title = {Overexpression of the erythropoietin receptor is associated with upregulation of tubulin beta 6 and paclitaxel resistance in ovarian adenocarcinoma cells},
journal = {Acta Chimica Slovenica},
year = {2026},
volume = {73},
number = {1},
pages = {258--266},
doi = {10.17344/acsi.2025.9420}
}
EUVIMED